These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29112936)

  • 1. Designing anti-Zika virus peptides derived from predicted human-Zika virus protein-protein interactions.
    Kazmirchuk T; Dick K; Burnside DJ; Barnes B; Moteshareie H; Hajikarimlou M; Omidi K; Ahmed D; Low A; Lettl C; Hooshyar M; Schoenrock A; Pitre S; Babu M; Cassol E; Samanfar B; Wong A; Dehne F; Green JR; Golshani A
    Comput Biol Chem; 2017 Dec; 71():180-187. PubMed ID: 29112936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Breakthroughs in Structure-based Design of Synthetic and Natural Sourced Inhibitors Against Zika Viral Targets.
    Nandi S; Kaur R; Kumar M; Sharma A; Naaz A; Mandal SC
    Curr Top Med Chem; 2018; 18(20):1792-1803. PubMed ID: 30465510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear import inhibitor N-(4-hydroxyphenyl) retinamide targets Zika virus (ZIKV) nonstructural protein 5 to inhibit ZIKV infection.
    Wang C; Yang SNY; Smith K; Forwood JK; Jans DA
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1555-1559. PubMed ID: 28988109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive virus yield assay for evaluation of Antivirals against Zika Virus.
    Goebel S; Snyder B; Sellati T; Saeed M; Ptak R; Murray M; Bostwick R; Rayner J; Koide F; Kalkeri R
    J Virol Methods; 2016 Dec; 238():13-20. PubMed ID: 27678028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysulfonate suramin inhibits Zika virus infection.
    Tan CW; Sam IC; Chong WL; Lee VS; Chan YF
    Antiviral Res; 2017 Jul; 143():186-194. PubMed ID: 28457855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Targets for
    Esteves E; Rosa N; Correia MJ; Arrais JP; Barros M
    Biomed Res Int; 2017; 2017():1734151. PubMed ID: 29379794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Annotation of Mature Peptides and Genotypes for Zika Virus.
    Sun G; Larsen CN; Baumgarth N; Klem EB; Scheuermann RH
    PLoS One; 2017; 12(1):e0170462. PubMed ID: 28125631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host Proteins Involved in Zika Virus Infection.
    Xin QL; Deng CL; Chen X; Wang J; Wang SB; Wang W; Deng F; Zhang B; Xiao G; Zhang LK
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS; Chu YK; Golden JE; Chung DH
    Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening.
    Singh A; Jana NK
    Comput Biol Chem; 2017 Dec; 71():144-151. PubMed ID: 29096380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of protein evolution in the genome of pre-epidemic and epidemic Zika virus.
    Ramaiah A; Dai L; Contreras D; Sinha S; Sun R; Arumugaswami V
    Infect Genet Evol; 2017 Jul; 51():74-85. PubMed ID: 28315476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures.
    Elfiky AA; Ismail AM
    SAR QSAR Environ Res; 2018 May; 29(5):409-418. PubMed ID: 29652194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZikaBase: An integrated ZIKV- Human Interactome Map database.
    Gurumayum S; Brahma R; Naorem LD; Muthaiyan M; Gopal J; Venkatesan A
    Virology; 2018 Jan; 514():203-210. PubMed ID: 29197720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of diagnostic peptide regions that distinguish Zika virus from related mosquito-borne Flaviviruses.
    Lee AJ; Bhattacharya R; Scheuermann RH; Pickett BE
    PLoS One; 2017; 12(5):e0178199. PubMed ID: 28562637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles.
    Albulescu IC; Kovacikova K; Tas A; Snijder EJ; van Hemert MJ
    Antiviral Res; 2017 Jul; 143():230-236. PubMed ID: 28461070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing: New Treatments for Zika Virus Infection?
    Cheng F; Murray JL; Rubin DH
    Trends Mol Med; 2016 Nov; 22(11):919-921. PubMed ID: 27692879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a high-throughput colorimetric Zika virus infection assay.
    Müller JA; Harms M; Schubert A; Mayer B; Jansen S; Herbeuval JP; Michel D; Mertens T; Vapalahti O; Schmidt-Chanasit J; Münch J
    Med Microbiol Immunol; 2017 Apr; 206(2):175-185. PubMed ID: 28176006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.